Literature DB >> 6248917

Effect of beta-endorphin and naloxone on acquisition, memory, and retrieval of shuttle avoidance and habituation learning in rats.

I Izquierdo.   

Abstract

Naloxone impairs acquisition of shuttle avoidance behavior (0.8 mg/kg IP) and habituation to a rearing response to a tone (1.6 mg/kg IP) in rats. beta-Endorphin (2 microgram/kg IP) has no effect on acquisition, but, when given prior to test sessions, facilitates retrieval of the two tasks. Naloxone has no effect of its own upon retrieval. In addition to these effects, the pretraining administration of beta-endorphin disrupts, and that of naloxone facilitates retention of the two tasks. The results are consistent with the hypothesis that these two forms of learning are state-dependent on the release of beta-endorphin (and, perhaps, of other opiate peptides as well), that this substance is released during training in a sufficient amount for this purpose, and that, in addition, there is a physiological amnesic mechanism mediated by opiate peptides. Furthermore, the results are also consistent with previous observations that beta-endorphin is released from the rat brain during training, but not during test sessions of the two tasks (Izquierdo et al., 1980b). The possibility is discussed that state-dependency and the amnesic effect comprise one single, rather than two separate mechanisms.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6248917     DOI: 10.1007/bf00426531

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  20 in total

1.  Effect of naloxone and morphine on various forms of memory in the rat: possible role of engogenous opiate mechanisms in memory consolidation.

Authors:  I Izquierdo
Journal:  Psychopharmacology (Berl)       Date:  1979-11       Impact factor: 4.530

2.  Effect of hippocampal and neocortical spreading depression on rat shuttle behavior in four different experimental paradigms.

Authors:  E A Cavalheiro; I Izquierdo
Journal:  Physiol Behav       Date:  1977-06

3.  Alpha-methyl-p-tyrosine and memory: state-dependency and memory failure.

Authors:  S F Zornetzer; M S Gold; J Hendrickson
Journal:  Behav Biol       Date:  1974-09

4.  Naloxone enhancement of memory.

Authors:  R B Messing; R A Jensen; J L Martinez; V R Spiehler; B J Vasquez; B Soumireu-Mourat; K C Liang; J L McGaugh
Journal:  Behav Neural Biol       Date:  1979-11

5.  The effect of pre- and post-trial amphetamine injections on avoidance responses of rats.

Authors:  A M Evangelista; I Izquierdo
Journal:  Psychopharmacologia       Date:  1971

6.  Post-training intraperitoneal administration of leu-enkephalin and beta-endorphin causes retrograde amnesia for two different tasks in rats.

Authors:  I Izquierdo; A C Paiva; E Elisabetsky
Journal:  Behav Neural Biol       Date:  1980-02

7.  Facilitation of memory processing by posttrial morphine: possible involvement of reinforcement mechanisms?

Authors:  C Mondadori; P G Waser
Journal:  Psychopharmacology (Berl)       Date:  1979-06-21       Impact factor: 4.530

8.  Beta-endorphin causes retrograde amnesia and is released from the rat brain by various forms of training and stimulation.

Authors:  I Izquierdo; D O Souza; M A Carrasco; R D Dias; M L Perry; S Eisinger; E Elisabetsky; D A Vendite
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

9.  Role of the hippocampus in blocking and conditioned inhibition of the rabbit's nictitating membrane response.

Authors:  P R Solomon
Journal:  J Comp Physiol Psychol       Date:  1977-04

10.  Memory facilitation by naloxone is due to release of dopaminergic and beta-adrenergic systems from tonic inhibition.

Authors:  I Izquierdo; M Graudenz
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

View more
  16 in total

1.  Differential prevention of morphine amnesia by antisense oligodeoxynucleotides directed against various Gi-protein alpha subunits.

Authors:  N Galeotti; C Ghelardini; A Bartolini
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  The effects of acute and chronic steady state methadone on memory retrieval in rats.

Authors:  Erin Cummins; Craig P Allen; Alexander Ricchetti; Emily Boughner; Kayla Christenson; Megan Haines; Cheryl L Limebeer; Linda A Parker; Francesco Leri
Journal:  Psychopharmacology (Berl)       Date:  2012-01-19       Impact factor: 4.530

3.  Retrograde memory enhancement by diazepam: its relation to anterograde amnesia, and some clinical implications.

Authors:  L Cahill; J Brioni; I Izquierdo
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Opiate states of memory: receptor mechanisms.

Authors:  L A Bruins Slot; F C Colpaert
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

Review 5.  Neurotransmitter replacement therapy in Alzheimer's disease.

Authors:  E Mohr; T Mendis; I N Rusk; J D Grimes
Journal:  J Psychiatry Neurosci       Date:  1994-01       Impact factor: 6.186

6.  Facilitation or inhibition of memory by morphine: a question of experimental parameters.

Authors:  W Classen; C Mondadori
Journal:  Experientia       Date:  1984-05-15

7.  Effects of intrahippocampally-injected naloxone and morphine upon behavioural responses to novelty in mice from two selectively-bred lines.

Authors:  J H van Abeelen; J H van Nies
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

Review 8.  Advances in the pharmacotherapy of Alzheimer's disease.

Authors:  J C Soares; S Gershon
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

9.  State dependent and/or direct memory retrieval by morphine in mice.

Authors:  M Nishimura; Y Shiigi; H Kaneto
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

10.  The influence of adrenergic receptor antagonists on the amnestic and antiamnestic actions of adrenaline and tyramine.

Authors:  I Izquierdo; R D Dias
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.